To access this element change to forms mode OFF
Grant Award View - GA207625
Adrenal-Targeted Nanobiotechnology: A Novel Therapy for Adrenal Disease
GA ID:
GA207625
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
4-Jan-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$733,194.50
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Adrenal-Targeted Nanobiotechnology: A Novel Therapy for Adrenal Disease
Purpose:
The adrenal gland produces hormones essential for life-long health. Conditions related to the disruption of these hormones affect 4 million Australians annually, at a cost of $2 Billion. Adrenal conditions require life-long drug replacement therapy, with no possibility of a cure. Through the use of a new adrenal specific delivery technology, we aim to develop novel drug treatments and single-injection cures for adrenal disease.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2012273
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The University of Newcastle
Recipient ABN:
15 736 576 735
Grant Recipient Location
Suburb:
Callaghan
Town/City:
Callaghan
Postcode:
2308
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, NSW
Postcode:
Multiple
Country:
AUSTRALIA